Eventide Asset Management, LLC Pliant Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $297,917 - $599,235	-42,499 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.26 $26.3 Million - $39.1 Million	-2,140,739 Reduced 98.05%	42,499 $574,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $4.76 Million - $8.37 Million	-288,654 Reduced 11.68%	2,183,238 $36.9 Million
Q1 2021 May 14, 2021	SELL	$24.52 - $40.23 $8.98 Million - $14.7 Million	-366,233 Reduced 12.9%	2,471,892 $97.2 Million
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $60.5 Million - $100 Million	2,838,125 New	2,838,125 $88.4 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.